2) benazepril hydrochloride
盐酸贝那普利
1.
Study on the absorption kinetics of benazepril hydrochloride;
盐酸贝那普利大鼠在体小肠吸收动力学
2.
A HPLC method with chiral mobile phase additive was established for the determination of isomers of benazepril hydrochloride.
建立了HPLC-手性流动相添加剂法检测盐酸贝那普利及其异构体。
3.
Patients took valsartan 160 mg/d in ARB group(n=20),or benazepril hydrochloride 20 mg/d in benazepril group(n=20),or valsartan 160 mg/d plus benazepril hydrochloride in combined therapy group(n=21) for six months.
方法61例患者随机分为三组:缬沙坦组(对照1组)(n=20),服用缬沙坦160 mg/d,贝那普利组(对照2组)(n=20)服用盐酸贝那普利20 mg/d。
3) Benazepril Hcl
盐酸贝那普利
1.
Effect of Benazepril Hcl and Losartan on serum matrix metalloproteinases-1,matrix metalloproteinases-9,tissue inhibitor of metailoproteinases-1,tissue inhibitor of metalloproteinases-4 levels in patients of congestive heart failure.;
盐酸贝那普利与氯沙坦对充血性心力衰竭患者血清基质金属蛋白酶的影响
2.
Effects of benazepril HCl on left ventricular diastolic function and serum brain natriuretic peptide level in patients with essential hypertension;
盐酸贝那普利对原发性高血压左室舒张功能及血清脑钠肽浓度的影响
4) Benazepril
盐酸贝那普利
1.
A group were given Benazepril.
方法:以60名正常人为对照,研究98名原发性高血压患者的血压、MMPI、LES、SS、HAMA、HAMD,皮质醇、促肾上腺皮质激素及血小板5-羟色胺,并将患者随机分为盐酸贝那普利治疗组(A组)和盐酸贝那普利加用帕罗西汀治疗组(B组),在服药第28天末比较A、B两组患者的血压变化、HAMA及HAMD得分变化等。
2.
Objective: To observe the clinical efficacy of insulin glargine,acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的:观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
3.
Objective To investigate the effects of Benazepril on apoptosis induced by hypoxia / reoxygenation in cultured neonatal rat cardiomyocytes.
目的探讨盐酸贝那普利对缺氧复氧乳鼠心肌细胞凋亡的影响及其作用机制。
6) Benazepril
贝那普利
1.
The effects of valsartan and benazepril on the exercise blood pressure of patients with primary hypertension;
缬沙坦与贝那普利对原发性高血压患者运动血压的影响
2.
Effect of angiotensinⅡand benazepril on remodeling of cardiac gap junction connexin43;
血管紧张素Ⅱ对心肌缝隙连接蛋白43重构的影响及贝那普利的干预作用
3.
Effect of benazepril and diltiazem on endothelium function in patients with cardiac syndrome X;
贝那普利、地尔硫对心脏X综合征患者内皮功能的影响
补充资料：盐酸贝那普利
分子式：C24H28N2O5.HCl;C24H29ClN2O5
分子量：460.96
CAS号：86541-74-4
性质：
分子量：460.96
CAS号：86541-74-4
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条